Search

Operation results are presented of a UV-sensitive gaseous photomultiplier (GPM) coupled through a MgF2 window to a liquid-xenon scintillator. It consisted of a reflective CsI photocathode deposited on top of a THick Gaseous Electron Multiplier (THGEM); further multiplication stages were either a second THGEM or a Parallel Ionization Multiplier (PIM) followed by a MICROMEsh GAseous Structure (MICROMEGAS). The GPM operated in gas-flow mode with non-condensable gas mixtures. Gains of 10^4 were measured with a CsI-coated double-THGEM detector in Ne/CH4 (95:5), Ne/CF4 (95:5) and Ne/CH4/CF4 (90:5:5), with soft X-rays at 173 K. Scintillation signals induced by alpha particles in liquid xenon were measured here for the first time with a double-THGEM GPM in He/CH4 (92.5:7.5) and a triple-structure THGEM/PIM/MICROMEGAS GPM in Ne/CH4 (90:10) with a fast-current preamplifier., Comment: 12 pages, 9 figures, submitted to JINST

The Beta autoradiography is widely used in pharmacology or in biological fields to study the response of an organism to a certain kind of molecule. The image of the distribution is processed by studying the concentration of the radioactivity into different organs. We report on the development of an integrated apparatus based on a PIM device (Parallel Ionization Multiplier) able to process the image of 10 microscope slides at the same time over an area of 18*18 cm2. Thanks to a vacuum pump and a regulation gas circuit, 5 minutes is sufficient to begin an acquisition. All the electronics and the gas distribution are included in the structure leading to a transportable device. Special software has been developed to process data in real time with image visualization. Biological samples can be labelled with β emitters of low energy like 3H/14C or Auger electrons of 125I/99mTc. The measured spatial resolution is 30 μm in 3H and the trigger and the charge rate are constant over more than 6 days of acquisition showing good stability of the device. Moreover, collaboration with doctors and biologists of INSERM (National Institute for Medical Research in France) has started in order to demonstrate that MPGD's can be easily proposed outside a physics laboratory.